Skip to main content
. Author manuscript; available in PMC: 2014 Feb 21.
Published in final edited form as: Prostate. 2013 Jul 3;73(14):1518–1528. doi: 10.1002/pros.22699

TABLE I.

Demographic and Clinical Characteristics of Prostate Cancer Cases and Controls

Cases (N = 527) Controls (N = 558)

Continuous variables Mean (SD) Mean (SD) P-valuea
Age, years 63.4 (9.3) 56.8 (10.6) <0.001***
Body-mass index, (kg/m2) 27.9 (8.6) 29.6 (10.6) 0.02*
Income, $ 000 43.7 (29.5) 48.8 (28.8) 0.02*
Prostate-specific antigen (ng/ml) 81.5 (615.2) 1.2 (1.1) 0.02*
Categorical variables % % P-valueb
Cigarette-use
 Never Smoker 44.3 50.3 0.16*
 Current Smoker 30.4 28.2
 Former Smoker 25.2 21.5
Heavy smoking
 Greater than 20 cigarettes per day 14.8 21.1 0.04*
Alcohol-use
 Ever 77.6 74.7 0.29*
 Alcohol Frequency
 Greater than 10 drinks per week 14.8 10.5 0.04*
Education
 High school diploma or equivalent 84.8 94.3 <0.001***
Marital status
 Married 29.7 22.2 0.01
Poverty
 Less than $20,000 37.2 26.9 0.003
Obesity
 Obese (BMI ≥ 30) 24.8 34.9 0.003**
Race
 African American 79.9 71.3
 European American 20.1 28.7 0.001**
Tumor characteristics %
Gleason score
 4–6 54.3
 7c 30.4
 8–10 15.3
NCCN risk category
 Low-risk 39.2
 Intermediate 30.3
 High-risk 30.6
a

Unpaired, two-sample t-test.

b

Chi-square analysis; BMI, body mass index; TNM, Tumor node metastasis staging.

c

Includes both Gleason 3 + 4 and Gleason 4 + 3 tumors.

*

P < 0.05.

**

P < 0.01.

***

P < 0.001.